Charles River Laboratories Intl

Doris Richards
January 13, 2018

The company has market cap of $67.68 million. The hedge fund held 1.11M shares of the consumer non-durables company at the end of 2017Q3, valued at $6.32M, up from 774,927 at the end of the previous reported quarter.

Several hedge funds have recently modified their holdings of the company. The stock decreased 0.42% or $0.37 during the last trading session, reaching $86.77. About 20.57M shares traded. It has outperformed by 75.66% the S&P500. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Charles River Laboratories Intl.by 12.7% during the 2nd quarter. Healthinvest Partners Ab sold 9,400 shares as the company's stock rose 1.24% with the market. The firm had revenue of $464.23 million for the quarter, compared to analyst estimates of $458.93 million. (Put) (NASDAQ:NFLX) by 8,584 shares in the quarter, leaving it with 1,500 shares, and cut its stake in Unitedhealth Group Inc (Put) (NYSE:UNH). The stock decreased 1.32% or $1.45 during the last trading session, reaching $108.4. About 181,715 shares traded.

Charles River Laboratories International, Inc. has a 1-year low of $65.70 and a 1-year high of $89.18. (NYSE:CRL) has risen 7.06% since January 9, 2017 and is uptrending. It has underperformed by 9.64% the S&P500.The move comes after 9 months negative chart setup for the $5.13 billion company.

In other Charles River Laboratories International news, Director Stephen D. Chubb sold 4,564 shares of Charles River Laboratories International stock in a transaction on Friday, December 2nd. Therefore 77% are positive. SunTrust has "Buy" rating and $113.0 target. Charles River Laboratories International had a return on equity of 26.58% and a net margin of 10.72%. (NYSE:CRL) has "Hold" rating given on Thursday, October 12 by KeyBanc Capital Markets. Finally, Van Berkom & Associates Inc. increased its stake in Charles River Laboratories International by 5.1% in the third quarter.

A number of equities analysts recently weighed in on CRL shares. Jefferies maintained Charles River Laboratories International, Inc. The stock has "Sell" rating by UBS on Tuesday, September 6. As per Monday, November 13, the company rating was maintained by Robert W. Baird. The Switzerland-based Credit Suisse Ag has invested 0.01% in Charles River Laboratories International, Inc. (Put) (NASDAQ:NFLX) stake by 8,584 shares to 1,500 valued at $272,000 in 2017Q3.


Since January 1, 0001, it had 0 insider buys, and 6 selling transactions for $4.64 million activity. Molho Davide sold 6,165 shares worth $678,150.

Shares of Charles River Laboratories Intl. (NYSE:CRL) shares with value of $2.72 million were sold by JOHST DAVID P. On Monday, August 14 the insider Smith David Ross sold $171,228. The shares were sold at an average price of $109.44, for a total value of $543,588.48.

Investors sentiment increased to 1.46 in 2017 Q3. Its up 0.09, from 1.37 in 2017Q2. It also increased its holding in Ishares Russell Midcap (IWR) by 4,760 shares in the quarter, for a total of 192,000 shares, and has risen its stake in Coherent Inc. Chartwell Investment Partners LLC raised its stake in Charles River Laboratories Intl.by 0.4% during the second quarter. Aqr Capital Mgmt Limited Liability Corporation stated it has 0.19% of its portfolio in Charles River Laboratories International, Inc. (NYSE:CRL). Amalgamated Financial Bank owns 9,391 shares or 0.03% of their USA portfolio. Jefferies Group lifted their price target on shares of Charles River Laboratories Intl. from $120.00 to $130.00 and gave the stock a "buy" rating in a research note on Monday, October 9th. (NYSE:CRL) or 6,060 shares. Ameriprise Fincl reported 185,847 shares. Snyder Cap Mngmt LP reported 53,413 shares. Century Inc has invested 0% in Charles River Laboratories International, Inc. (NYSE:CRL) or 14,015 shares. Alps Advisors Inc. raised its stake in Charles River Laboratories Intl.by 0.3% during the second quarter. (NYSE:CRL) or 1,760 shares. Morgan Stanley reported 899,582 shares. (NASDAQ:ICON). Price T Rowe Md has 60,868 shares for 0% of their portfolio. (NYSE:CRL). Eagle Asset Mgmt reported 321,341 shares. Amp Cap Invsts has 8,667 shares. Royal Bank of Canada started coverage on Charles River Laboratories International in a research report on Tuesday, September 19th. (NYSE:CRL) for 144,395 shares. Therefore 71% are positive. Charles River Laboratories had 39 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has "Outperform" rating given on Friday, August 28 by William Blair. Robert W. Baird upgraded Gentex Corporation (NASDAQ:GNTX) on Thursday, August 24 to "Outperform" rating. KeyBanc Capital Markets maintained the stock with "Hold" rating in Thursday, October 12 report. As per Wednesday, April 27, the company rating was maintained by CLSA. The rating was initiated by Susquehanna with "Neutral" on Monday, December 19. As per Thursday, September 22, the company rating was maintained by RBC Capital Markets. The rating was downgraded by Craig Hallum to "Hold" on Monday, July 24. The firm earned "Outperform" rating on Thursday, January 7 by Wells Fargo. Bessemer Grp holds 0% in Charles River Laboratories International, Inc. Cognex Corp. (NASDAQ:CGNX) was reduced too.

Investors sentiment increased to 1.24 in 2017 Q3. Its up 0.09, from 1.37 in 2017Q2. Chartwell Investment Partners LLC now owns 50,028 shares of the medical research company's stock worth $5,060,000 after buying an additional 186 shares during the last quarter. King Luther Corp reported 357,775 shares or 0.06% of all its holdings. Prelude Cap Management Ltd Limited Liability Company accumulated 3,039 shares. Bnp Paribas Arbitrage has 0.01% invested in Charles River Laboratories International, Inc. Johnson Inv Counsel accumulated 40,120 shares. Jennison Limited Liability Company reported 17,241 shares. Qci Asset Management Incorporated holds 1,040 shares. Bridgeway Capital Mgmt has 0.02% invested in Quanex Building Products Corporation (NYSE:NX) for 70,000 shares. Prudential Financial invested in 261,150 shares.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER